Support Revised Campaign for Cures to Raise
$1,000,000 For Our Next Milestones

For Detailed Information About the Institute's Coronavirus Research Program, Go to This Link.

Amount Further Needed to be Raised in 2021

$300,000 left

The 2021 Financial Goal for the "Campaign for Cures" has been updated to Support Research for Developing COVID-19 Vaccines and Therapies for the Institute's Therapeutic Priorities

The financial needs for the "Campaign for Cures" has been revised from $750,000 to $1,000,000.  The cost has increased because of increased costs from supply chains and subcontractors as a result of COVID.  We are pleased to report that we have achieved scientific milestones on time and within budget.  However, the cost has increased because the Institute needs to test vaccines in an academic BSL3 facility that is certified to contain infectious pathogens like COVID-19.  These studies are expensive and is a government requirement.  The objectives for 2021 is to raise $1,000,000 before the end of the year to help defray the cost of producing a pipeline of attenuated vaccines; produce new adult stem cells for vaccine testing; and conducting preclinical animal testing to identify the lead vaccine candidate that will graduate and be subjected to more rigorous animal efficacy and safety studies.  For 2021, we have raised $400,000 of our goal of $1,000,000.  Additionally, these funds will also be used to also cover the research costs to advance adult stem cell research for our Therapeutic Priorities.  The funds raised by the "Campaign for Cures" has achieved important research milestones.  These research milestones will hopefully lead to more effective and moral coronavirus vaccines than those currently approved under the Emergency Use Authorization, which were designed, manufactured and tested with aborted fetal cells. Please join this important campaign by making a meaningful, tax-deductible contribution and earmark your donation towards our "Campaign for Cures" program.  To learn more about our "Campaign for Cures" for developing a COVID-19 vaccine, go to this link.  We have provided a link to address the frequently asked questions regarding the Institute's COVID-19 vaccine research program.

JP2MRI Audio & Video Gallery


Audio and Video Gallery for the John Paul II Medical Research Institute.

Capital Campaign


The John Paul II Medical Research Institute (JP2MRI) is conducting a One Million Dollar Capital Campaign Drive to start the process of developing adult stem cell therapies.

Physician Registry


The Institute needs physicians to volunteer to identify and recruit patients to participate in obtaining tissue samples from patients to create induced pluripotent stem (IPS) cells. 



Subscribe to our newsletters and download prior newsletters.

The John Paul II Medical Research Institute (JP2MRI) focuses on the most ethical and cost-effective way of conducting medical research to help develop therapies and cures for a variety of diseases. Most diseases share a common technical requirement to create therapies. The Institute’s research focuses on these common technical requirements by recruiting patients to procure tissue to develop stem cells and cancer cells for medical research.


The Institute differentiates itself from other research organizations in the following manner:


1. We do NOT support embryonic stem cell research. We support research that is pro-life driven.


2. We devote more than half of our budget towards medical research, which is far greater than most established foundations.


We need your support now.

Patient Registry


This is a patient registry form for anyone who has a genetic disorder who would like to join. All data will be held confidentially, obtained voluntarily, and will never be shared with third parties. Once you're done, click Submit.

Fundraising Opportunities

Learn how organized groups can hold a fundraiser on behalf of JP2MRI and keep 50% of proceeds for your own group's local efforts.

The service of humanity leads us to insist, in season and out of season, that those using the latest advances of science, especially in the field of biotechnology, must never disregard fundamental ethical requirements by invoking a questionable solidary which eventually leads to discriminating between one life and another and ignoring the dignity which belongs to every human being.

St. Pope John Paul II

For updated research on coronavirus, click on this link